From the article:
One person who won’t be meeting with Sen. Bernie Sanders (I-Vt.) anytime soon is Martin Shkreli, the CEO of Turing Pharmaceuticals who made news when his company announced it was raising the price of a life-saving medication from $13.50 a pill to $750.
Sanders has been vocal about wanting to have Medicare negotiate lower drug prices and letting people import less-expensive prescription drugs from Canada, and Shkreli told Stat he wanted to explain to him how drug prices are set. In order to secure a face-to-face meeting, Shkreli said that on Sept. 28 he donated $2,700 to Sanders, the maximum individual contribution allowed. He received an automated thank you letter at the time, but now, the Sanders campaign said the money is going to be donated to the Whitman-Walker health clinic in Washington, D.C., and Shkreli will not be meeting with the Democratic presidential candidate. “We are not keeping the money from this poster boy for drug company greed,” campaign spokesman Michael Briggs said Thursday.
0 Responses
Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.